The European Association of Nuclear Medicine (EANM), the world-leading society for nuclear medicine, molecular imaging and theranostics, is pleased to announce the EANM Focus Meeting – an annual conference in a new format that will take place in the first months of each year. It will supplement the very successful EANM Annual Congress in October and the educational events organised by EANM/ESMIT.
Wim J.G. Oyen, MD, PhD
(EANM President elect)
Stefano Fanti, MD
(Chair of the Scientific Programme)
At the EANM Focus Meeting, a multidisciplinary group of experts and opinion leaders from all over the world will present state-of-the-art lectures and participate in consensus panels. The first EANM Focus Meeting will be on molecular imaging and theranostics in prostate cancer. We are very pleased that a large faculty of oncologists, urologists, imagers, clinical and basic scientists and patient-advocates has agreed to lecture and participate in the discussions. They will provide an in-depth overview of the current state of the art and future directions in the management of prostate cancer, with a focus on the role of imaging in general and nuclear medicine in particular, now and in the future. Based on the conference’s results, a consensus statement will be produced. As the lectures and discussions will be at an advanced level and do not aim to provide basic overviews and education, the meeting will be particularly advantageous to clinicians who are already engaged in the diagnosis and treatment of prostate cancer.
You are cordially invited to attend the first EANM Focus Meeting in the SH Valencia Palace Hotel in Valencia, Spain, on February 1–3, 2018. Registrations are limited to 250 participants and will be allocated on a first-come, first-served basis, so please reserve your attendance as soon as possible.
We hope to welcome you to the beautiful city of Valencia in February 2018 for what promises to be an exciting new EANM initiative.
With best personal regards,
Wim J.G. Oyen and Stefano Fanti